Circio Holding Future Growth
Future criteria checks 4/6
Circio Holding is forecast to grow earnings and revenue by 87.4% and 84.4% per annum respectively. EPS is expected to grow by 105.9% per annum. Return on equity is forecast to be 216.7% in 3 years.
Key information
87.4%
Earnings growth rate
105.9%
EPS growth rate
| Biotechs earnings growth | 26.7% |
| Revenue growth rate | 84.4% |
| Future return on equity | 216.7% |
| Analyst coverage | Low |
| Last updated | 27 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 272 | 198 | N/A | N/A | 1 |
| 12/31/2025 | 148 | 19 | 135 | 137 | 2 |
| 12/31/2024 | N/A | -68 | -70 | -68 | 1 |
| 12/31/2023 | 0 | -111 | -89 | -89 | N/A |
| 9/30/2023 | 10 | -446 | -103 | -98 | N/A |
| 6/30/2023 | 10 | -449 | -115 | -110 | N/A |
| 3/31/2023 | 10 | -440 | -112 | -107 | N/A |
| 12/31/2022 | 10 | -433 | -114 | -109 | N/A |
| 9/30/2022 | N/A | -107 | -105 | -105 | N/A |
| 6/30/2022 | N/A | -110 | -94 | -94 | N/A |
| 3/31/2022 | N/A | -106 | -91 | -91 | N/A |
| 12/31/2021 | N/A | -98 | -85 | -85 | N/A |
| 9/30/2021 | N/A | -98 | -87 | -87 | N/A |
| 6/30/2021 | 0 | -97 | -94 | -94 | N/A |
| 3/31/2021 | 0 | -105 | -100 | -100 | N/A |
| 12/31/2020 | 1 | -108 | -111 | -111 | N/A |
| 9/30/2020 | 3 | -117 | -122 | -122 | N/A |
| 6/30/2020 | 3 | -120 | -128 | -128 | N/A |
| 3/31/2020 | 3 | -132 | -134 | -134 | N/A |
| 12/31/2019 | 2 | -148 | -143 | -143 | N/A |
| 9/30/2019 | 0 | -153 | -135 | -135 | N/A |
| 6/30/2019 | 0 | -162 | -132 | -132 | N/A |
| 3/31/2019 | 0 | -153 | -125 | -125 | N/A |
| 12/31/2018 | 0 | -147 | -112 | -112 | N/A |
| 9/30/2018 | 0 | -139 | -111 | -111 | N/A |
| 6/30/2018 | 0 | -132 | -108 | -108 | N/A |
| 3/31/2018 | 0 | -129 | -112 | -112 | N/A |
| 12/31/2017 | 0 | -122 | -108 | -107 | N/A |
| 9/30/2017 | 0 | -121 | N/A | -106 | N/A |
| 6/30/2017 | 0 | -119 | N/A | -102 | N/A |
| 3/31/2017 | 0 | -118 | N/A | -104 | N/A |
| 12/31/2016 | 0 | -122 | N/A | -109 | N/A |
| 9/30/2016 | 0 | -134 | N/A | -120 | N/A |
| 6/30/2016 | 0 | -137 | N/A | -129 | N/A |
| 3/31/2016 | 0 | -117 | N/A | -105 | N/A |
| 12/31/2015 | 0 | -92 | N/A | -81 | N/A |
| 9/30/2015 | 0 | -57 | N/A | -54 | N/A |
| 6/30/2015 | 0 | -32 | N/A | -28 | N/A |
| 3/31/2015 | 0 | -22 | N/A | -18 | N/A |
| 12/31/2014 | 0 | -18 | N/A | -14 | N/A |
| 9/30/2014 | -3 | -12 | N/A | -8 | N/A |
| 6/30/2014 | -1 | -10 | N/A | -7 | N/A |
| 3/31/2014 | 0 | -9 | N/A | -9 | N/A |
| 12/31/2013 | 0 | -8 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRNAO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: CRNAO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRNAO is expected to become profitable in the next 3 years.
Revenue vs Market: CRNAO is forecast to have no revenue next year.
High Growth Revenue: CRNAO is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRNAO's Return on Equity is forecast to be very high in 3 years time (216.7%).